AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MESOBLAST LTD

1.845

-0.035-1.86%

Volume:3.53M

Turnover:6.61M

Market Cap:2.36B

PE:-12.89

High:1.905

Open:1.880

Low:1.845

Close:1.880

Loading ...

Overview Company News Filings

Bullish Mesoblast Insiders Loaded Up On US$145.4m Of Stock

Simply Wall St.

Up 19% in a month, what's driving Mesoblast shares?

Mesoblast shares dip then flip on $800,000 insider buy

Caution! 11 stocks on the ‘avoid’ list for 2025

BRIEF-Mesoblast Says Raises A$260 Million For Ryoncil Commercial Launch

Why Mesoblast, Myer, Premier Investments, and Vulcan shares are falling today

BUZZ-Australia's Mesoblast slides on discounted placement

Mesoblast Raises AU$260 Million via Private Placement; Shares Down 7%

MT Newswires Live

Why is the Mesoblast share price crashing 9% today?

Mesoblast - Placement at a$2.50 per Share

THOMSON REUTERS

Mesoblast Ltd - Raises a$260 Mln for Ryoncil Commercial Launch

THOMSON REUTERS

Here's how the ASX 200 market sectors stacked up last week

3 ASX small-cap shares that ripped 295% to 900% in 2024

Mesoblast Says JPMorgan Chase Reduces Shareholding

MT Newswires Live

HotCopper users flock to make sense of darling Mesoblast’s ‘proposed financing’

The Market Herald

Why are Mesoblast shares in a trading halt?

Mesoblast Requests Trading Halt

MT Newswires Live

BRIEF-Mesoblast Ltd Seeks Trading Halt

16 ASX shares that doubled in value last year

ASX Market Close: IT pulls index higher, but miners & utilities drag | January 7, 2025

The Market Herald

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MSB.AU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":1.845,"timestamp":1746166320000,"preClose":1.88,"halted":0,"volume":3531023,"delay":0,"nameEN":"MESOBLAST LTD","floatShares":784338594,"shares":1277239284,"eps":-0.14313217499224326,"marketStatus":"Market Closed","change":-0.035,"latestTime":"05-02 16:12:00 AEST","open":1.88,"high":1.905,"low":1.845,"amount":6605433,"amplitude":0.031915,"askPrice":1.855,"askSize":10000,"bidPrice":1.845,"bidSize":3849,"shortable":3,"etf":0,"ttmEps":-0.14313217499224326,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746403200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":1.88,"openAndCloseTimeList":[[1746144000000,1746165600000]],"volumeRatio":0.7330209700160539,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":784338594,"roa":"-4.85%","roe":"-21.31%","lyrEps":-0.138289,"volumeRatio":0.7330209700160539,"shares":1277239284,"dividePrice":0,"high":1.905,"amplitude":0.031915,"preClose":1.88,"low":1.845,"week52Low":0.88,"pbRate":"3.29","psRate":"267.90","week52High":3.37,"institutionHeld":0,"latestPrice":1.845,"committee":-0.444148,"eps":-0.14313217499224326,"divideRate":0,"volume":3531023,"delay":0,"ttmEps":-0.14313217499224326,"open":1.88,"prevYearClose":3.1,"prevWeekClose":1.79,"prevMonthClose":1.795,"prevQuarterClose":1.96,"fiveDayClose":1.79,"twentyDayClose":1.935,"sixtyDayClose":3.19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB.AU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2505024706","title":"Bullish Mesoblast Insiders Loaded Up On US$145.4m Of Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2505024706","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505024706?lang=en_us&edition=fundamental","pubTime":"2025-01-24 05:57","pubTimestamp":1737669458,"startTime":"0","endTime":"0","summary":"Multiple insiders secured a larger position in Mesoblast Limited  shares over the last 12 months. This is reassuring as this suggests that insiders have increased optimism about the company's prospects.While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Mesoblast. O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bullish-mesoblast-insiders-loaded-us-215738998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7067","BK7508","BK4139","MESO","MSB.AU","BK7501"],"gpt_icon":1},{"id":"2505073164","title":"Up 19% in a month, what's driving Mesoblast shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2505073164","media":"MotleyFool","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505073164?lang=en_us&edition=fundamental","pubTime":"2025-01-22 07:26","pubTimestamp":1737502001,"startTime":"0","endTime":"0","summary":"Following the FDA approval, Mesoblast completed a $260 million capital raising, priced at $2.50 per share.  As we reported at the time, this was a 47% premium to its share price just a month earlier. Management said the funds would support the commercial launch of Ryoncil in the US and further clinical developments. These include the \"acceleration\" of the second Phase 3 trial investigating Ryoncil for treating inflammatory chronic low back pain. Phase 3 trials are the final stage for any treatment before it is approved for the US market. Management also said it would use part of the funds to expand its manufacturing capacity, to meet the expected demand for these therapies if they were approved. As for broker ratings, the stock is rated a buy from the consensus of analyst estimates, according to CommSec.  The average price target amongst these analysts is $3.79 apiece, as per Tradingview broker data. This implies a 32% upside potential from Mesoblast's closing price on Tuesday. Fool","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/22/up-19-in-a-month-whats-driving-mesoblast-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4139","BK7067","BK7501","MSB.AU","MESO","BK7508"],"gpt_icon":0},{"id":"2505260805","title":"Mesoblast shares dip then flip on $800,000 insider buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2505260805","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505260805?lang=en_us&edition=fundamental","pubTime":"2025-01-21 09:17","pubTimestamp":1737422246,"startTime":"0","endTime":"0","summary":"Mesoblast Ltd shares started Tuesday trading in the red before reversing direction amid news of a major company insider purchase. The Mesoblast share price is $2.81, up 1.08% at the time of writing. The ASX biotechshare is outperforming the S&P/ASX All Ordinaries Index, which is up 0.36%. What's been happening lately?) on 2 January. Are Mesoblast shares a buy?For now, John Athanasiou of Red Leaf Securities has a hold rating on Mesoblast shares.  He recommends that existing shareholders and poten","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/21/mesoblast-shares-dip-then-flip-on-800000-insider-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["ADS.AU","BK7016","BK4139","MSB.AU","XAO.AU","BK7508","BK7067","BK7501","MESO"],"gpt_icon":0},{"id":"2503106676","title":"Caution! 11 stocks on the ‘avoid’ list for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503106676","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503106676?lang=en_us&edition=fundamental","pubTime":"2025-01-16 04:00","pubTimestamp":1736971228,"startTime":"0","endTime":"0","summary":"You can watch the video by clicking the player, listen to the podcast, or read an edited transcript below. These interviews were filmed on Tuesday, 10 December 2024.Everyone is hunting for the next big winner in the stock market, but sometimes it pays to go back to basics. Where is a better place to start than by drawing on the wisdom of the Oracle of Omaha, Warren Buffett?Note: We would like to thank the fund managers listed above for sharing their top ideas for 2025 in the spirit of the Outlook Series. All of the fund managers featured in this series run diversified portfolios and do not invest solely in the stocks mentioned below. This list is not, nor is it intended to be, a set of recommendations. Please do your own research and seek advice from a professional before making any investment decisions of your own. Past performance is not a reliable indi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/caution-11-stocks-on-the-avoid-list-for-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/caution-11-stocks-on-the-avoid-list-for-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU1852331112.SGD","LU0323591593.USD","LU1917777945.USD","NXT.AU","LU0823434740.USD","LOV.AU","LU0154236417.USD","LU1267930227.SGD","LU0149725797.USD","LU0107464264.USD","MSB.AU","LU2242649171.HKD","LU0077335932.USD","LU0310799852.SGD","SIQ.AU","IE00B5949003.HKD","LU2458330169.SGD","LU0345770993.USD","GOOGL","LU2065171402.SGD","LU0994945656.USD","MMS.AU","BK4548","LU1066051225.USD","LU0820562030.AUD","IE0034235303.USD","LU0943347566.SGD","LU0792757196.USD","EQNR","IE0005OL40V9.USD","LU1868836914.USD","BK4532","LU0787776722.HKD","IE0034235188.USD","LU1815333072.USD","BK7128","LU2491050154.USD","USJW.SI","LU0234572021.USD","LU1267930813.SGD","IPH.AU","APE.AU","BRN.AU","LU1935043023.USD","PWR.AU","LU0724617625.USD","GOOG","LU0096362180.USD","LU2592432038.USD","LU0203347892.USD"],"gpt_icon":1},{"id":"2503569714","title":"BRIEF-Mesoblast Says Raises A$260 Million For Ryoncil Commercial Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2503569714","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503569714?lang=en_us&edition=fundamental","pubTime":"2025-01-14 09:25","pubTimestamp":1736817907,"startTime":"0","endTime":"0","summary":"Jan 14 (Reuters) - Mesoblast   :   * RAISES A$260 MILLION FOR RYONCIL COMMERCIAL LAUNCH   * PLACEMENT AT A$2.50 PER SHAREFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-Mesoblast Says Raises A$260 Million For Ryoncil Commercial Launch","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK4139","BK7501","BK7067","BK7508","MESO"],"gpt_icon":0},{"id":"2503566675","title":"Why Mesoblast, Myer, Premier Investments, and Vulcan shares are falling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2503566675","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503566675?lang=en_us&edition=fundamental","pubTime":"2025-01-14 08:57","pubTimestamp":1736816224,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is bouncing back from yesterday's selloff and is pushing higher. At the time of writing, the benchmark index is up 0.4% to 8,225.4 points. Four ASX shares that have fai","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/14/why-mesoblast-myer-premier-investments-and-vulcan-shares-are-falling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7021","BK7145","MSB.AU","BK7508","BK4139","BK7095","BK7504","BK7067","BK7501","BK7029","MYR.AU","PMV.AU","LHM.AU","BK7153","MESO","XJO.AU","VUL.AU"],"gpt_icon":1},{"id":"2503356566","title":"BUZZ-Australia's Mesoblast slides on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2503356566","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503356566?lang=en_us&edition=fundamental","pubTime":"2025-01-14 08:38","pubTimestamp":1736815115,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mesoblast slides on discounted placement** Shares of Mesoblast MSB.AX fall as much as 9.3% to A$2.55, their largest intraday pct loss since Dec 20** Stock hits lowest level since Dec 24** The drug developer completes private placement to raise A$260 mln ** Placement issue price at A$2.5 per share, representing an 11% discount to stock's last close** Co says funds to be used for the U.S. commercial launch of its Ryoncil therapy for the treatment of graft-versus-host disease, among others** Stock down 15.2% YTD, including current session's moves     ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nL4N3OA017:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MSB.AU","BK7501","BK7067"],"gpt_icon":0},{"id":"2503568255","title":"Mesoblast Raises AU$260 Million via Private Placement; Shares Down 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503568255","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503568255?lang=en_us&edition=fundamental","pubTime":"2025-01-14 08:09","pubTimestamp":1736813343,"startTime":"0","endTime":"0","summary":"Mesoblast  completed a global private placement to existing US, UK, and Australian shareholders, raising AU$260 million at AU$2.50 per share, according to a Tuesday filing with the Australian bourse.The proceeds will fund the US commercial launch of Ryoncil for pediatric steroid-refractory acute graft-versus-host disease, accelerate the second phase three study in inflammatory chronic low back pain, expand commercial manufacturing activities, and fund working capital and general corporate purposes, the filing said.The company's shares fell almost 7% in recent Tuesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7067","MESO","XKO.AU","MSB.AU","BK7501","BK7508","XJO.AU","BK4139"],"gpt_icon":0},{"id":"2503568843","title":"Why is the Mesoblast share price crashing 9% today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2503568843","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503568843?lang=en_us&edition=fundamental","pubTime":"2025-01-14 07:47","pubTimestamp":1736812027,"startTime":"0","endTime":"0","summary":"The Mesoblast Ltd  share price has returned from its trading halt and dropped into the red. At the time of writing, the biotech company's shares are down 9% to $2.55. Why is the Mesoblast share price sinking today?The catalyst for today's weakness has been news that Mesoblast has successfully completed a major capital raising. According to the release, the allogeneic cellular medicines developer for inflammatory diseases has completed a global private placement primarily to its existing major US, UK, and Australian shareholders. This has seen the high-flying company raise a total of A$260 million  at a price of A$2.50 per new share. This represents a discount of 11% to where the Mesoblast share price last traded. Unfortunately for retail shareholders, they have been excluded from this capital raising. The company has no plans to launch a share purchase plan  on this occasion. Why is the company raising funds?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/14/why-is-the-mesoblast-share-price-crashing-9-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","BK7508","BK4139","BK7501","MSB.AU","MESO"],"gpt_icon":0},{"id":"2503552407","title":"Mesoblast - Placement at a$2.50 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2503552407","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503552407?lang=en_us&edition=fundamental","pubTime":"2025-01-14 07:10","pubTimestamp":1736809813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O91YD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7508","MSB.AU","MESO","BK4139"],"gpt_icon":0},{"id":"2503552288","title":"Mesoblast Ltd - Raises a$260 Mln for Ryoncil Commercial Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2503552288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503552288?lang=en_us&edition=fundamental","pubTime":"2025-01-14 07:10","pubTimestamp":1736809813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O91YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","MESO","BK7067","BK4139","MSB.AU"],"gpt_icon":0},{"id":"2502878743","title":"Here's how the ASX 200 market sectors stacked up last week","url":"https://stock-news.laohu8.com/highlight/detail?id=2502878743","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502878743?lang=en_us&edition=fundamental","pubTime":"2025-01-12 05:00","pubTimestamp":1736629200,"startTime":"0","endTime":"0","summary":"ASX200 healthcareshares led themarket sectorswith a 1.15% increase over the five trading days. The S&P/ASX 200 Index(ASX: XJO) gained 0.53% over the week to finish at 8,294.1 points on Friday. Seven o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/12/heres-how-the-asx-200-market-sectors-stacked-up-last-week-22/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SIG.AU","PME.AU","BK7007","BK7124","BK7508","SHL.AU","BK7067","BK7096","TLX.AU","CSL.AU","RMD.AU","BK7501","BK7103","COH.AU","BK7094","MSB.AU","BK7113","FPH.AU","BK7511","RHC.AU","CU6.AU","XJO.AU"],"gpt_icon":0},{"id":"2502883159","title":"3 ASX small-cap shares that ripped 295% to 900% in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2502883159","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502883159?lang=en_us&edition=fundamental","pubTime":"2025-01-10 12:08","pubTimestamp":1736482139,"startTime":"0","endTime":"0","summary":"ASX small-cap shares put in a solid performance last year, with the S&P/ASX Small Ordinaries Index (ASX: XSO) rising 5.54% and delivering total returns, including dividends, of 8.36%.  By comparison, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/10/3-asx-small-cap-shares-that-ripped-295-to-900-in-2024/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["ZIP.AU","BK7116","BK7096","BK7501","XKO.AU","SIG.AU","BK7084","BK7103","BK7093","BK7067","BK7508","BK7016","PNI.AU","CU6.AU","SPR.AU","XJO.AU","IPX.AU","SLC.AU","BK7104","XAO.AU","MSB.AU","BK7062","NXL.AU","BK7015","360.AU","CDA.AU"],"gpt_icon":0},{"id":"2502005712","title":"Mesoblast Says JPMorgan Chase Reduces Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2502005712","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502005712?lang=en_us&edition=fundamental","pubTime":"2025-01-10 10:21","pubTimestamp":1736475703,"startTime":"0","endTime":"0","summary":"Mesoblast  said JPMorgan Chase & Co and its affiliates reduced their voting power in the company to 7.16% from 8.34% on Tuesday, according to a Friday filing with the Australian bourse.The financial services firm and its affiliates reduced its shareholdings in the biotechnology firm to 82,2 million shares from 95.3 million shares as of the last notice dated Dec. 19, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","MESO","JPM","BK4139","MSB.AU","BK7508","BK7501"],"gpt_icon":0},{"id":"2502100322","title":"HotCopper users flock to make sense of darling Mesoblast’s ‘proposed financing’","url":"https://stock-news.laohu8.com/highlight/detail?id=2502100322","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502100322?lang=en_us&edition=fundamental","pubTime":"2025-01-10 09:44","pubTimestamp":1736473440,"startTime":"0","endTime":"0","summary":"If you’ve been paying attention, you know Mesoblast  is currently something of an Australian market darling.Just take a look at its recent run. One-year returns are currently up +868%, borne largely from the US FDA’s decision to approve Mesoblast’s drug Ryoncil in mid-December.For those who remember Droneshield’s stellar run through the first half of last year , it’s safe to say Mesoblast took the crown as market darling right before the clinching point of 2024.Mesoblast has since popped to a $3 billion-plus market cap.Maybe not quite WA1 Resources  tier growth, but still impressive enough in what was a fairly dry 2024 when it came to stock picking.Boring stocks like Coles , CBA , and Woolworths  will always be advisable  but what the trading community really wants is to behave like smart money.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/hotcopper-users-flock-to-make-sense-of-darling-mesoblasts-proposed-financing-2025-01-10/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7082","BK7040","WA1.AU","BK4139","BK7041","HVN.AU","BK7135","MESO","BK7153","BK7067","CBA.AU","COL.AU","BK7508","BK7501","MSB.AU","BK7095","WOW.AU","BK7511"],"gpt_icon":0},{"id":"2502005926","title":"Why are Mesoblast shares in a trading halt?","url":"https://stock-news.laohu8.com/highlight/detail?id=2502005926","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502005926?lang=en_us&edition=fundamental","pubTime":"2025-01-10 08:44","pubTimestamp":1736469874,"startTime":"0","endTime":"0","summary":"The Mesoblast Ltd share price is going nowhere after the company requested a trading haltthis morning.  Mesoblast requested that the trading halt remain in place ahead of an announcement about \"a proposed financing\". The company revealed no other details in its formal request.  The ASX confirmed Mesoblast shares would remain frozen until the earlier of the announcement or the start of trading next Tuesday.  Mesoblast share price on hold ahead of financing news  Mesoblast was the number one S&P/ASX All Ordinaries Index share for price growth in 2024. The ASX biotechshare rose by an astounding 900% to finish the year at $3.10 apiece on 31 December. Already in the new year, Mesoblast shares have hit a four-year high of $3.37.  They closed at $2.81 apiece yesterday.  What powered the 900% rise in Mesoblast shares last year?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/10/why-are-mesoblast-shares-in-a-trading-halt/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["MSB.AU","BK7067","MSC","XAO.AU","MESO","BK4150","BK4139","BK7501","BK4575","BK7508"],"gpt_icon":0},{"id":"2502507620","title":"Mesoblast Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2502507620","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502507620?lang=en_us&edition=fundamental","pubTime":"2025-01-10 07:39","pubTimestamp":1736465963,"startTime":"0","endTime":"0","summary":"Mesoblast  requested that its securities be placed in trading halt until an announcement related to a proposed financing is made, according to a Friday filing with the Australian bourse.The trading halt will remain in place until the start of trading on Jan. 14 or when the company makes the financing announcement, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MSB.AU","BK7067","XKO.AU","XAO.AU","XJO.AU","MESO","BK4139","BK7501","BK7508"],"gpt_icon":0},{"id":"2502807374","title":"BRIEF-Mesoblast Ltd Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2502807374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502807374?lang=en_us&edition=fundamental","pubTime":"2025-01-10 06:58","pubTimestamp":1736463537,"startTime":"0","endTime":"0","summary":"BRIEF-Mesoblast Ltd Seeks Trading HaltJan 10 (Reuters) - Mesoblast Ltd MSB.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PROPOSED FINANCINGFurther company coverage: MSB.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250109:nFWN3O50SC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","BK4139","MSB.AU","MESO","BK7501"],"gpt_icon":0},{"id":"2502088116","title":"16 ASX shares that doubled in value last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2502088116","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502088116?lang=en_us&edition=fundamental","pubTime":"2025-01-09 04:00","pubTimestamp":1736366400,"startTime":"0","endTime":"0","summary":"S&P/ASX All Ordinaries Index (ASX: XAO) shares rose by 7.55% last year and delivered total gross returns, including dividends, of 11.44%. The index closed the year at 8,420.5 points.  In comparison, t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/09/16-asx-shares-that-doubled-in-value-last-year/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","SIG.AU","XJO.AU","LIF","SLC.AU","BK7016","NXL.AU","BK7084","BK7104","PME.AU","MSB.AU","BK7096","APX.AU","BK7062","PNI.AU","BK7503","TNE.AU","BK7116","BK7501","SPR.AU","BK7015","IPX.AU","BK7061","CU6.AU","360.AU","TLX.AU","ZIP.AU","BK7103","OBM.AU","BK4023","XAO.AU","BK7094","CAT.AU","BK7067","BK7093"],"gpt_icon":0},{"id":"2501441672","title":"ASX Market Close: IT pulls index higher, but miners & utilities drag | January 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501441672","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501441672?lang=en_us&edition=fundamental","pubTime":"2025-01-07 13:54","pubTimestamp":1736229240,"startTime":"0","endTime":"0","summary":"The ASX200 pared intra-day gains, closing up 0.34% at 8,285 points, retreating from a fresh three week high of 8,297 points.IT was the biggest winner, up 1.46%, followed by Telecommunication, up 1.25%, and Discretionary, up 0.72%. Utilities was the worst performer, down 0.87%, followed by Materials, down 0.54%.4DMedicalclosed up 14.7% after receiving US FDA clearance for its IQ-UIP product. An advanced AI-driven diagnostic tool that identifies Usual Interstitial Pneumonia, the product is a key radiological marker for diagnosing Interstitial Pulmonary Fibrosis.Santos finished up 1.4% following pleading guilty to charges related to a 2022 petroleum spill at its Varanus Island Marine Terminal which was linked to dolphin deaths.Capricorn Metals  closed up 2.2% on release of the gold miner’s quarterly update. The company’s Karlawinda Gold Project delivered another strong quarter of operations, producing 28,702 ounces of gold.Fortescue  closed down 4.4% in response to iron ore falling to aro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-it-pulls-index-higher-but-miners-utilities-drag-january-7-2025-2025-01-07/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7129","BK7094","BK7067","BK7104","MSB.AU","STO.AU","BK7508","BK7016","BK7501","BRN.AU","BK7142","BK7507","4DX.AU","CMM.AU","FMG.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":166,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[]}}